Replies to post #17784 on Anavex Life Sciences Corp (AVXL)

[maskone]

They had better act fast because after another round of positive results, they will need more than 10billion to afford this!

[The_Pro]

So, the moral of the story is an up to $10 billion offer is in the works.

Not to mention other contenders entering.

$10 billion MC = $83.33/share
120M shares

Say all 165 Million shares will be available, then we are at $60.60/share.

I guess peeps are overzealous with $100.00+ pps.

Wild interpretation here.

[stealthways]

Gilead can write a check now for $24 billion ($14 Billion on hand plus the $10 new debt)... but this is small compared to what they have available for an acquisition(s) since they are cash flowing about $22 billion per year on top of that... this gives them a lot of room for more debt and also Buy outs are usually financed by a combination of equity and debt...IMO Gilead could spend up to $2 or $3 hundred billion on acquisitions (of promising Biotech plays) with their current capital structure...